These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36129029)

  • 1. CEBPB regulates the bile acid receptor FXR to accelerate colon cancer progression by modulating aerobic glycolysis.
    Wang Z; Pang J; Wang L; Dong Q; Jin D
    J Clin Lab Anal; 2022 Nov; 36(11):e24703. PubMed ID: 36129029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FXR silencing in human colon cancer by DNA methylation and KRAS signaling.
    Bailey AM; Zhan L; Maru D; Shureiqi I; Pickering CR; Kiriakova G; Izzo J; He N; Wei C; Baladandayuthapani V; Liang H; Kopetz S; Powis G; Guo GL
    Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G48-58. PubMed ID: 24177031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.
    Peng Z; Chen J; Drachenberg CB; Raufman JP; Xie G
    J Biol Chem; 2019 May; 294(21):8529-8542. PubMed ID: 30967475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription Factor FXR Activates DHRS9 to Inhibit the Cell Oxidative Phosphorylation and Suppress Colon Cancer Progression.
    Zhao J; Wang Y; Wang Y; Gao J; Yang H; Wu X; Li H
    Anal Cell Pathol (Amst); 2022; 2022():8275574. PubMed ID: 36340269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-192 suppresses the expression of the farnesoid X receptor.
    Krattinger R; Boström A; Schiöth HB; Thasler WE; Mwinyi J; Kullak-Ublick GA
    Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1044-51. PubMed ID: 27079614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor.
    Yang F; Hu Y; Liu HX; Wan YJ
    J Biol Chem; 2015 Mar; 290(10):6507-15. PubMed ID: 25596928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K; Kim YM; Kim YW; Kim SG
    Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer.
    De Gottardi A; Touri F; Maurer CA; Perez A; Maurhofer O; Ventre G; Bentzen CL; Niesor EJ; Dufour JF
    Dig Dis Sci; 2004 Jun; 49(6):982-9. PubMed ID: 15309887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acids and colon cancer: Is FXR the solution of the conundrum?
    Gadaleta RM; Garcia-Irigoyen O; Moschetta A
    Mol Aspects Med; 2017 Aug; 56():66-74. PubMed ID: 28400119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis.
    Lax S; Schauer G; Prein K; Kapitan M; Silbert D; Berghold A; Berger A; Trauner M
    Int J Cancer; 2012 May; 130(10):2232-9. PubMed ID: 21780109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages.
    Cao S; Meng X; Li Y; Sun L; Jiang L; Xuan H; Chen X
    Front Immunol; 2021; 12():632864. PubMed ID: 33968024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids.
    Frankenberg T; Rao A; Chen F; Haywood J; Shneider BL; Dawson PA
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G912-22. PubMed ID: 16357058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis.
    Yu J; Li S; Guo J; Xu Z; Zheng J; Sun X
    Cell Death Dis; 2020 Aug; 11(8):640. PubMed ID: 32807788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.
    Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ
    J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the intestinal nuclear bile acid farnesoid X receptor (FXR) by the caudal-related homeobox 2 (CDX2).
    Modica S; Cariello M; Morgano A; Gross I; Vegliante MC; Murzilli S; Salvatore L; Freund JN; Sabbà C; Moschetta A
    J Biol Chem; 2014 Oct; 289(41):28421-32. PubMed ID: 25138215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes.
    Caron S; Huaman Samanez C; Dehondt H; Ploton M; Briand O; Lien F; Dorchies E; Dumont J; Postic C; Cariou B; Lefebvre P; Staels B
    Mol Cell Biol; 2013 Jun; 33(11):2202-11. PubMed ID: 23530060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of bile acids on the growth of human cholangiocarcinoma via FXR.
    Dai J; Wang H; Shi Y; Dong Y; Zhang Y; Wang J
    J Hematol Oncol; 2011 Oct; 4():41. PubMed ID: 21988803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.